Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,122 | -99 | -3,887 | -7,631 | -5,457 |
| Depreciation Amortization | 192 | 199 | 236 | 175 | 692 |
| Income taxes - deferred | -15,267 | -52 | N/A | N/A | 3 |
| Accounts receivable | N/A | N/A | N/A | N/A | 560 |
| Other Working Capital | 1,679 | -545 | 102 | -81 | 1,493 |
| Other Operating Activity | 53,201 | -5,515 | -137 | 5,948 | 2,288 |
| Operating Cash Flow | $-10,317 | $-6,012 | $-3,686 | $-1,589 | $-421 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -339 | -5 | -4 | -152 | -575 |
| Net Acquisitions | N/A | 783 | N/A | N/A | 586 |
| Sale Of Investment | N/A | 7,900 | N/A | N/A | N/A |
| Other Investing Activity | 77 | -2,596 | 0 | 0 | 0 |
| Investing Cash Flow | $-262 | $6,082 | $-4 | $-152 | $10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 3,750 | 2,750 |
| Debt Repayment | N/A | N/A | N/A | -2,650 | -2,726 |
| Common Stock Issued | 15,885 | 2,866 | 7 | 650 | 705 |
| Other Financing Activity | 0 | 0 | 0 | -36 | -154 |
| Financing Cash Flow | $15,885 | $2,866 | $7 | $1,714 | $576 |
| Beginning Cash Position | 3,970 | 1,034 | 4,717 | 35 | 252 |
| End Cash Position | 9,276 | 3,970 | 1,034 | 8 | 416 |
| Net Cash Flow | $5,306 | $2,936 | $-3,683 | $-27 | $165 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,317 | -6,012 | -3,686 | -1,589 | -421 |
| Capital Expenditure | -339 | -5 | -4 | -152 | -575 |
| Free Cash Flow | -10,656 | -6,017 | -3,690 | -1,741 | -996 |